文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

长链非编码 RNA,一种混合 HLA Ⅰ类内源性逆转录病毒基因:结构、表达及与疾病的关联。

Long Noncoding RNA , a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations.

机构信息

Faculty of Health and Medical Sciences, UWA Medical School, The University of Western Australia, Crawley, WA 6009, Australia.

Department of Molecular Life Science, Division of Basic Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara 259-1193, Japan.

出版信息

Cells. 2019 May 20;8(5):480. doi: 10.3390/cells8050480.


DOI:10.3390/cells8050480
PMID:31137555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6562477/
Abstract

The RNA gene (NCBI ID: 10866) is located centromeric of the gene and between the and genes within the major histocompatibility complex (MHC) class I region. It is a human species-specific gene that codes for a long noncoding RNA (lncRNA), composed mostly of an ancient ancestral endogenous antisense 3' long terminal repeat (LTR, and part of the internal antisense sequence of endogenous retrovirus (ERV) type 16 linked to a human leukocyte antigen (HLA) class I promoter and leader sequence at the 5'-end. Since its discovery in 1993, many disease association and gene expression studies have shown that is a regulatory lncRNA involved in adaptive and innate immune responses and associated with the promotion of some autoimmune diseases and cancers. The gene sequence acts as a genomic anchor point for binding transcription factors, enhancers, and chromatin remodeling enzymes in the regulation of transcription and chromatin folding. The antisense retroviral transcript also interacts with regulatory microRNA and immune and cellular checkpoints in cancers suggesting its potential as a drug target for novel antitumor therapeutics.

摘要

RNA 基因(NCBI ID:10866)位于基因的着丝粒中心,位于主要组织相容性复合体(MHC)I 类区域的基因和基因之间。它是一种人类种特异性基因,编码长非编码 RNA(lncRNA),主要由古老的内源性反义 3'长末端重复(LTR 和部分内源性逆转录病毒(ERV)类型 16 的内部反义序列组成,与人类白细胞抗原(HLA)I 类启动子和 5'端的前导序列相连。自 1993 年发现以来,许多疾病关联和基因表达研究表明,是一种调节性 lncRNA,参与适应性和先天免疫反应,并与某些自身免疫性疾病和癌症的发生有关。基因序列作为基因组锚定点,用于结合转录因子、增强子和染色质重塑酶,调节转录和染色质折叠。反义逆转录病毒转录本还与癌症中的调节 microRNA 和免疫及细胞检查点相互作用,表明其作为新型抗肿瘤治疗药物的潜在靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/00e5c214e30e/cells-08-00480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/5e181732cf67/cells-08-00480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/d7ac378e23af/cells-08-00480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/e580b8519a1d/cells-08-00480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/f8ac4ace2fbe/cells-08-00480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/00e5c214e30e/cells-08-00480-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/5e181732cf67/cells-08-00480-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/d7ac378e23af/cells-08-00480-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/e580b8519a1d/cells-08-00480-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/f8ac4ace2fbe/cells-08-00480-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baa3/6562477/00e5c214e30e/cells-08-00480-g005.jpg

相似文献

[1]
Long Noncoding RNA , a Hybrid HLA Class I Endogenous Retroviral Gene: Structure, Expression, and Disease Associations.

Cells. 2019-5-20

[2]
Comparison between two human endogenous retrovirus (HERV)-rich regions within the major histocompatibility complex.

J Mol Evol. 1999-6

[3]
The P5 multicopy gene family in the MHC is related in sequence to human endogenous retroviruses HERV-L and HERV-16.

Immunogenetics. 1999-5

[4]
Long non-coding RNA HCP5 in cancer.

Clin Chim Acta. 2021-1

[5]
A polymorphism in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro.

AIDS. 2010-1-2

[6]
Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region.

Immunogenetics. 2004-8

[7]
The role of human endogenous retroviral long terminal repeat sequences in human cancer (Review).

Int J Mol Med. 2013-7-30

[8]
Utility of next-generation RNA-sequencing in identifying chimeric transcription involving human endogenous retroviruses.

APMIS. 2016

[9]
Use of the HCP5 single nucleotide polymorphism to predict hypersensitivity reactions to abacavir: correlation with HLA-B*5701.

J Antimicrob Chemother. 2010-6-9

[10]
An endogenous retroviral element exerts an antiviral innate immune function via the derived lncRNA lnc-ALVE1-AS1.

Antiviral Res. 2019-7-30

引用本文的文献

[1]
LncRNA HCP5 promotes the progression of gastric cancer through the miR-526b/PBX3 axis.

Am J Transl Res. 2025-7-25

[2]
Transposable elements may enhance antiviral resistance in HIV-1 elite controllers.

Genome Biol. 2025-2-24

[3]
Targeted Variant Assessments of Human Endogenous Retroviral Regions in Whole Genome Sequencing Data Reveal Retroviral Variants Associated with Papillary Thyroid Cancer.

Microorganisms. 2024-11-27

[4]
Genetic Architecture of Idiopathic Inflammatory Myopathies From Meta-Analyses.

Arthritis Rheumatol. 2025-6

[5]
Local genetic correlation via knockoffs reduces confounding due to cross-trait assortative mating.

Am J Hum Genet. 2024-12-5

[6]
Preliminary Data on SNP of Transplantation-Related Genes after Haploidentical Stem Cell Transplantation.

J Clin Med. 2024-8-9

[7]
Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications.

Noncoding RNA Res. 2024-5-20

[8]
Human Endogenous Retroviruses in Breast Cancer: Altered Expression Pattern Implicates Divergent Roles in Carcinogenesis.

Oncology. 2024

[9]
Genetic changes from type I interferons and JAK inhibitors: clues to drivers of juvenile dermatomyositis.

Rheumatology (Oxford). 2024-9-1

[10]
HLA-DPB1 genotype variants predict DP molecule cell surface expression and DP donor specific antibody binding capacity.

Front Immunol. 2024-1-11

本文引用的文献

[1]
HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.

Theranostics. 2019-4-13

[2]
Genome-wide DNA methylation analysis in ankylosing spondylitis identifies HLA-B*27 dependent and independent DNA methylation changes in whole blood.

J Autoimmun. 2019-5-23

[3]
HCP5 promotes colon cancer development by activating AP1G1 via PI3K/AKT pathway.

Eur Rev Med Pharmacol Sci. 2019-4

[4]
Long noncoding RNA HCP5 contributes to epithelial-mesenchymal transition in colorectal cancer through ZEB1 activation and interacting with miR-139-5p.

Am J Transl Res. 2019-2-15

[5]
, , , and Polymorphisms in Sjögren's Syndrome: Association with Disease Susceptibility and Clinical Aspects.

J Immunol Res. 2019-2-10

[6]
Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance.

Immunogenetics. 2019-1-31

[7]
SP1-induced upregulation of long non-coding RNA HCP5 promotes the development of osteosarcoma.

Pathol Res Pract. 2019-3

[8]
CTCF Expression is Essential for Somatic Cell Viability and Protection Against Cancer.

Int J Mol Sci. 2018-11-30

[9]
The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019.

Nucleic Acids Res. 2019-1-8

[10]
Targeting Long Noncoding RNA in Glioma: A Pathway Perspective.

Mol Ther Nucleic Acids. 2018-12-7

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索